Loading clinical trials...
Loading clinical trials...
Exploration and Study on the Identification of Various Pulmonary Diseases Using Volatile Organic Compounds Biomarkers in Human Exhaled Breath
Conditions
Interventions
Gas chromatography-mass spectrometry(GC-MS) and micro Gas Chromatography-photoionisation detector (μGC-PID) system
Locations
1
China
The First Affiliated Hospital of Guangzhou Medical University
Guangzhou, Guangdong, China
Start Date
June 30, 2024
Primary Completion Date
December 30, 2026
Completion Date
June 30, 2027
Last Updated
March 26, 2025
NCT06043817
NCT05671510
NCT07177937
NCT06426511
NCT06498635
NCT06257264
Lead Sponsor
ChromX Health
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions